Skip to main content
Clinical Trials/IRCT20170611034458N3
IRCT20170611034458N3
Recruiting
Phase 3

The effect of crocin supplementation on glycemic control, inflammatory factors, oxidative stress biomarkers, glomerular and tubular markers in patients with diabetic nephropathy: A randomized controlled clinical trial

Esfahan University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Diabetic nephropathy.
Sponsor
Esfahan University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with diabetic nephropathy aged 40 to 75 years
  • Moderate blood pressure (systolic pressure 140\-160 and diastolic pressure 90\-100 mm Hg)
  • Absence of urinary tract infection and any other disease that can cause proteinuria
  • Glomerular filtration rate more than 60 milliliters per minute.

Exclusion Criteria

  • Taking antioxidant supplements from three months before entering the study.
  • Patients who do not want to participate in the study or do not take medication regularly.
  • Taking steroidal immunosuppressive drugs (corticosteroids).
  • Suffering from certain cardiovascular diseases, cancer, inflammatory diseases, autoimmune disorders, or hyper\- or hypothyroidism.
  • Taking anticoagulants.
  • Having high blood pressure (systolic pressure above 140 and diastolic pressure above 90 mm Hg).
  • Smoking and alcohol use

Outcomes

Primary Outcomes

Not specified

Similar Trials